Table 2.

Characteristics of the patients in the finite NUC group at the time when HBsAg reached <0.05 IU/mL and the time when NUC therapy was withdrawn.

Characteristic	NUC withdrawal	HBsAg < 0.05 IU/mL	P
Age (years)	47.4 (28.1–65.5)	44.9 (25.7–65.5)	0.668
ALT (U/L)	24 (13–65)	27.5 (13–106)	0.756
Albumin (g/L)	47 (31.5–50.1)	46.9 (32.5–49.9)	0.822
Total bilirubin (μmol/L)	14.4 (7.3–42.5)	13.7 (5.6–48.0)	0.927